Investing Profile

Stephen Squinto

InvestorVC

Venture Partner at OrbiMed

orbimed.comNew York, New York

Your Intro Paths to Stephen Squinto

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Stephen is a member of

OrbiMed Network

32 CONNECTIONS

OrbiMed Network

32 CONNECTIONS

Find Stephen Squinto on

Current Investing Position

OrbiMed Venture Partner

Investment Range

$1M - $75.0M

Sweet Spot

$4.0M

Investments On Record

Current Fund Size

$18B

Stephen Squinto is on these Sector & Stage Rankings

Stephen Squinto's Investments On Record (11)

Company	StageDateRound Size	Total Raised
Enlaza Therapeutics	Series AApr 2024$100M	$160M
Co-investors: James N. Topper (Xelas Consulting LLC), Marcos Milla (Samsara BioCapital), Jay Lichter (Avalon Ventures)
Vanqua Bio	Series BSep 2021$85M	$85M
Co-investors: Jonathan Silverstein (OrbiMed), Bernard Davitian (Omega Funds), Mona Ashiya (OrbiMed Advisors), Sara Nayeem (Avoro Ventures)
iECURE	Series ASep 2021$50M	$120M
Co-investors: Tom Woiwode (Versant Ventures)
Gennao Bio	Series AMay 2021$40M	$40M
Co-investors: Chau Khuong (OrbiMed)
Chemomab	Post Ipo EquityMar 2021$46M	$76M
Co-investors: Peter Thiel (Founders Fund), Fabian Hansen (Presight Capital)
Gemini Therapeutics	Post Ipo EquityFeb 2021$95M Series AOct 2017$43M SeedApr 2016$2M	$140M
Co-investors: Carl Gordon (OrbiMed Advisors), Jean George (Advanced Technology Ventures), Jason Rhodes (Atlas Venture)
Compass Therapeutics	Series UnknownJun 2020$60M	$160M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Peter Thiel (Founders Fund), George Godula (Life Biosciences), Julie Sunderland (Biomatics Capital Partners), Carl Gordon (OrbiMed Advisors), Phil Ferneau (Borealis Ventures), Ben Auspitz (Forge Life Science Partners)
Passage Bio	Series AFeb 2019$120M	$230M
Co-investors: Liam Ratcliffe (New Leaf Venture Partners), Patrick Heron (Frazier Healthcare Partners), Carl Gordon (OrbiMed Advisors), Tom Woiwode (Versant Ventures)